The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection
- 21 February 2000
- Vol. 18 (16) , 1707-1711
- https://doi.org/10.1016/s0264-410x(99)00511-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coliVaccine, 2000
- Pneumococcal Diversity: Considerations for New Vaccine Strategies with Emphasis on Pneumococcal Surface Protein A (PspA)Clinical Microbiology Reviews, 1998
- Novel pneumococcal surface proteins: role in virulence and vaccine potentialTrends in Microbiology, 1998
- Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260Microbial Pathogenesis, 1994
- Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspAJournal of Bacteriology, 1994
- Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysisJournal of Bacteriology, 1992
- The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide VaccineNew England Journal of Medicine, 1991
- Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae.The Journal of Experimental Medicine, 1984
- Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within GroupsThe Journal of Infectious Diseases, 1983
- The Assessment of Pneumococcal VaccineNew England Journal of Medicine, 1980